ENvue Medical (FEED) Non-Current Deffered Revenue (2020 - 2024)

ENvue Medical (FEED) has reported Non-Current Deffered Revenue for 5 consecutive years, with $1000.0 the latest figure, recorded in Q2 2024.

• On a quarterly basis, Non-Current Deffered Revenue fell 98.81% year-over-year to $1000.0 in Q2 2024; TTM through Jun 2024 was $1000.0, a 98.81% decrease from a year earlier, with the FY2023 full-year figure at $15000.0, down 85.98% from the prior year.
• Non-Current Deffered Revenue was $1000.0 for Q2 2024 at ENvue Medical, down from $4000.0 in the prior quarter.
• Over five years, Non-Current Deffered Revenue peaked at $271000.0 in Q3 2021 and troughed at $1000.0 in Q2 2024.
• A 5-year average of $129352.9 and a median of $130000.0 in 2022 frame the typical range for Non-Current Deffered Revenue.
• Across the five-year window, Non-Current Deffered Revenue rose 26.05% in 2021 and sank 98.81% in 2024, its largest moves.
• Over 5 years, Non-Current Deffered Revenue stood at $199000.0 in 2020, then dropped by 23.12% to $153000.0 in 2021, then tumbled by 30.07% to $107000.0 in 2022, then slumped by 85.98% to $15000.0 in 2023, then plunged by 93.33% to $1000.0 in 2024.
• The last three Non-Current Deffered Revenue figures came in at $1000.0 (Q2 2024), $4000.0 (Q1 2024), and $15000.0 (Q4 2023), per Business Quant data.